HKEX: 1801 - Innovent Biologics, Inc.

Yield per half year: +0.939%
Dividend yield: 0.00%
Sector: Healthcare

Reporting Innovent Biologics, Inc.

Reports

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023
Финансовый отчет link link link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд ¥
23.67 31.61 66.24 114.59 46.76 62.75 50.87 64.39 14.70
Выручка, млрд ¥
0.0185 0.0095 1.05 3.84 4.27 4.56 6.21 6.21 3.99 42.69
Чистая прибыль, млрд ¥
-0.5042 -0.5623 -5.77 -1.72 -0.9984 -3.14 -2.18 -1.03 -1.03 -1.8137 -9.75
EV, млрд ¥
19.94 32.26 59.66 6.98 46.86 57.52 57.61 40.66 12.26
EBIT, млрд ¥
-0.4133 -0.6247 -1.55 -1.78 -0.1731 -2.99 -3.12 -1.9226 15.02
EBITDA, млрд ¥
-0.3587 -0.5636 -1.49 -1.69 -0.0875 -0.3554 -1.75 -1.75 -1.0746 3.27
Баланс стоимость, млрд ¥
-1.38 -1.94 4.19 4.76 8.78 10.33 10.73 12.53 12.53 9.43 21.36
FCF, млрд ¥
-0.4214 -0.5832 -1.33 -2.03 -1.08 -3.87 -3.3 -1.24 -1.24 -2.3040 -9.39
Операционный денежный поток, млрд ¥
-0.363 -0.4923 -1.02 -1.66 -0.3077 -2.02 -1.92 0.1478 0.1478 -1.1520 -161.65
Операционная прибыль, млрд ¥
-0.4133 -0.6247 -1.55 -1.78 -0.1731 -2.99 -2.07 -0.9092 -0.9092 -1.5845 -12.57
Операционные расходы, млрд ¥
0.4133 0.6433 1.56 2.7 4.02 6.66 7.14 7.12 7.12 5.53 21.40
CAPEX, млрд ¥
0.0584 0.091 0.3127 0.3659 0.7718 1.07 1.37 1.38 1.38 0.9915 30.41


Balance sheet

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд ¥
1.01 0.5105 4.53 2.43 7.76 8.38 0.6958 2.75 2.75 4.40 2.51
Short Term Investments ¥
0.7823 0.8095 0.0723 2.27 0.3573 0.6448 7.25 7.37 7.37 3.58 26.56
Total Receivables ¥
0.0153 0.0494 0.0212 0.25 0.4754 0.9684 0.5753 1.01 1.01 0.6558 32.21
Total Current Assets ¥
1.87 1.45 4.69 5.46 9.47 11.55 11.51 13.43 13.43 10.28 19.72
Чистые активы, млрд ¥
0.7719 0.7618 1.08 1.44 1.91 3.09 3.83 1.37 4.06 2.33 -0.99
Активы, млрд ¥
2.82 2.46 6.11 7.23 11.83 16.24 17.59 20.63 20.63 14.70 23.33
Short Term Debt ¥
0.7823 0.8095 0.01 2.27 0.255 0.9625 1.2 1.2 0.9395 160.52
Long Term Debt ¥
0.5 0.505 0.782 0.808 0.9252 2.02 2.31 2.33 2.33 1.68 23.59
Задолженность, млрд ¥
3.77 4.08 1.92 2.47 3.06 5.91 6.86 8.1 8.1 5.28 26.81
Чистый долг, млрд ¥
0.2693 0.804 -3.73 0.6515 -6.58 1.03 2.09 0.7762 0.7762 -0.4065 3.56
Долг, млрд ¥
1.28 1.31 0.792 3.08 1.18 3.52 3.23 1.98 21.86
Interest income ¥
0.0538 0.0572 0.069 0.0595 0.0684 0.0625 0.1017 0.4528 0.1490 50.06
Расходы на обслуживание долга ¥
0.0458 0.0169 0.069 0.0595 0.0684 0.0625 0.9467 0.0986 0.0986 0.2471 10.63
Чист. проц. доходы, млрд ¥
-0.0493 -0.0492 -0.0483 0.0432 -0.0684 -0.0625 0.0878 0.3542 0.4963 0.0709 52.32
Амортизация, млрд ¥
0.0546 0.0611 0.0641 0.0864 0.0856 0.0704 9.41
Себестоимость, млрд ¥
0.1249 0.3878 0.573 0.931 1.14 1.14 0.6313 55.62
Товарно материальные запасы ¥
0.0366 0.0577 0.0661 0.3586 0.7057 1.35 1.43 0.9681 0.9681 0.9625 21.97


Share

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.5225 -0.1453 -0.0712 -0.2553 -1.42 -0.6338 -0.6338 -0.5051 34.26
Цена акции ао 24.1 26.55 82.05 48.25 33.5 42.75 36.6 43 43 40.82 -2.28
Число акций ао, млн 1118.15 1118.15 334.68 1177.69 1262.56 1402.78 1462.11 1534.41 1621.83 1621.83 1456.74 5.14
FCF/акцию -0.3769 -1.74 -1.13 -1.61 -0.7695 -2.65 -2.15 -0.7619 -0.7619 -1.5883 -13.90


Efficiency

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 36.43 28.95 -137.6 -36.16 -11.37 -30.38 -20.7 -8.84 -8.84 7.91 -21.4900 -24.55
ROA, % -17.91 -22.88 -94.42 -23.79 -8.44 -19.32 -12.88 -5.38 -5.38 5.02 -13.9620 -25.72
ROS, % -3033.33 -60899.99 -164.19 -25.97 -73.5 -47.83 -16.56 -16.56 -16.56 -16.56 8.52 -34.2020 -25.77
ROCE, % 43.13 38.51 -37.02 -37.39 -1.97 -28.93 -22.16 0 0 0.37 -25.4940 -9.75
Ebit margin, % -169.76 -4.5 -69.99 -68.54 0 0 -78.1975 -20.29
Рентаб EBITDA, % -3040.39 -15706.86 -161.51 -2.28 -69.99 -38.39 -28.19 -28.19 -7.55 -60.0720 -29.47
Чистая рентаб, % -3033.33 -60899.99 -164.19 -25.97 -73.5 -47.83 -16.56 -16.56 8.53 -65.6100 -36.80
Operation Margin, % -3369.99 -16382.83 -169.76 -4.5 -69.99 -45.4 -14.65 -14.65 -14.65 -14.65 12.04 -31.8680 -26.86
Доходность FCF, % -5.61 -6.42 -1.63 -3.38 -7.06 -1.97 -4.0920 -21.04


Coefficients

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-4.1 -18.38 -66.35 -36.52 -21.46 -61.04 22.69 -40.7500 27.13
P/BV
5.64 6.65 7.54 11.09 4.17 4.53 4.54 3.03 6.80 -7.39
P/S
2497.46 30.17 17.23 26.84 9.83 9.14 9.16 8.76 18.64 -21.25
P/FCF
-17.81 -15.57 -61.37 -29.59 -14.17 -50.78 -41.17 -41.17 -41.17 -3.66 -35.3760 6.83
E/P
-0.2438 -0.0544 -0.0151 -0.0274 -0.0466 -0.0164 -0.0202 -0.0202 -0.0202 0.04 -0.0262 -5.92
EV/EBITDA
-13.39 -19.07 -681.81 -19.63 -26.78 -29.88 -5.04 -152.1360 14.87
EV/EBIT
-20.21 -628.01 -19.63 -15 0 0 0 -170.7125 -7.18
EV/S
2103.52 30.8 15.52 13.74 10.28 9.27 9.28 9.28 9.28 32.54 10.37 -7.55
EV/FCF
-15 -15.89 -55.27 -15.15 -14.2 -46.55 -46.62 -46.62 -46.62 4.53 -33.8280 25.21
Debt/EBITDA
-3.58 -2.33 -0.5321 -1.82 -13.49 -1.85 -1.85 -1.85 -1.85 0.71 -4.1720 0.33
Netdebt/Ebitda
-0.7507 -1.43 2.51 -0.3851 75.24 -1.19 -1.19 -0.4437 -0.4437 -0.4437 -0.56 14.39 -135.82
Debt/Ratio
0.4554 0.5349 0.1296 0.4256 0.0997 0.1707 0.1566 0.1566 0.1566 0.10 0.2018 -18.12
Debt/Equity
-0.9265 -0.6767 0.1888 0.647 0.1344 0.2811 0.7956 0.7956 0.7956 0.74 0.5307 4.22
Debt/Net Income
-2.54 -2.34 -0.1372 -1.79 -1.18 -3.43 -3.14 -3.14 -3.14 0.78 -2.5360 11.90
Бета
-4.25 -0.4558 0.8172 0.8172 0.31 -1.2962 -157.72
Индекс Альтмана
2.35 5.61 6.72 4.05 4.44 6.09 6.09 6.09 5.32 5.48 -1.95


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 2.64
Дивиденды / прибыль, %
0 21.26


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
5294 4872 -4.07